Perrigo announced the launch of over-the-counter Nicotine Polacrilex Mini Lozenge, the generic version of GlaxoSmithKline‘s Nicorette Mini Lozenge.

Nicorette is indicated to reduce withdrawal symptoms, including nicotine craving, associated with quitting smoking. Nicotine replacement therapy releases small, stable amounts of nicotine into the body to alleviate cravings and withdrawal symptoms.

Nicotine Polacrilex Mini Lozenge is mint-flavored and is available in 2mg and 4mg strengths. Perrigo has begun shipment of this product.

For more information call (866) 634-9120 or visit